SP
RMD icon

Symmetry Partners’s ResMed RMD Stock Holding History

Symmetry Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,447
Closed -$277K – 420
2024
Q2 		$277K Hold
1,447
– – 0.01% 429
2024
Q1 		$287K Sell
1,447
-1,316
-48% -$241K 0.02% 432
2023
Q4 		$478K Hold
2,763
– – 0.03% 291
2023
Q3 		$409K Hold
2,763
– – 0.02% 363
2023
Q2 		$604K Hold
2,763
– – 0.03% 284
2023
Q1 		$605K Hold
2,763
– – 0.03% 278
2022
Q4 		$575K Sell
2,763
-467
-14% -$103K 0.03% 293
2022
Q3 		$705K Hold
3,230
– – 0.05% 230
2022
Q2 		$677K Hold
3,230
– – 0.05% 244
2022
Q1 		$783K Hold
3,230
– – 0.05% 248
2021
Q4 		$841K Sell
3,230
-309
-9% -$80.2K 0.05% 253
2021
Q3 		$913K Hold
3,539
– – 0.06% 244
2021
Q2 		$872K Sell
3,539
-1,602
-31% -$337K 0.06% 262
2021
Q1 		$997K Sell
5,141
-111
-2% -$22.3K 0.07% 198
2020
Q4 		$1.12M Buy
5,252
+19
+0.4% +$3.79K 0.09% 164
2020
Q3 		$897K Buy
5,233
+2,225
+74% +$411K 0.08% 186
2020
Q2 		$578K Buy
3,008
+1,382
+85% +$226K 0.07% 124
2020
Q1 		$239K Buy
1,626
+310
+24% +$49.4K 0.05% 240
2019
Q4 		$204K Sell
1,316
-439
-25% -$63.3K 0.04% 320
2019
Q3 		$237K Sell
1,755
-686
-28% -$89.9K 0.05% 293
2019
Q2 		$298K Sell
2,441
-1,693
-41% -$188K 0.06% 252
2019
Q1 		$430K Buy
4,134
+658
+19% +$67.9K 0.07% 176
2018
Q4 		$396K Buy
+3,476
New +$372K 0.1% 139

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Symmetry Partners's RMD Position: Q3 2024 in Review

Symmetry Partners sold out of ResMed (RMD) in Q3 2024, closing a stake of 1,447 shares — an estimated $277K sold.

Symmetry Partners first reported a position in RMD in Q4 2018 and held it in 23 quarters. The position peaked at $1.12M in Q4 2020. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • Symmetry Partners reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
  • Symmetry Partners sold 1,447 ResMed shares in Q3 2024, an estimated $277K.
  • Symmetry Partners first reported a position in ResMed in Q4 2018 and held it in 23 quarters.
  • Symmetry Partners's ResMed position peaked at $1.12M in Q4 2020.
  • 801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on Symmetry Partners's 13F filing for Q3 2024, filed 29 Oct 2024.